Group 1: The radiotherapy for one of the included diseases will be done utilizing gyroscopic radiosurgery (ZAP-X). The prescribed dose, number of fractions, and prescribed isodose line will follow the
Sponsors
Europäisches Cyberknife Zentrum München-Großhadern, Europäisches Radiochirurgie Zentrum München
Conditions
C79.3
D32
D35.2
Q28.2
Q28.3
D33.3
D33.2
D44.7
C69.3
C69.4
C71
D43
G50.0
D33
E22.0
E22.1C79.3
D32
D35.2
Q28.2
Q28.3
D33.3
D44.7
C69.3
C69.4
C71
D43
G50.0
D33
E22.0
E22.1
Unknown Phase
Self-Shielding Gyroscopic Radiosurgery – A Prospective Analysis and Comparison.
RecruitingDRKS00025819
Start: 2022-10-03Target: 350Updated: 2025-04-07
Self-Shielding Gyroscopic Radiosurgery – a First Prospective Observational Study and Retrospective Comparison.
Active, not recruitingDRKS00025820
Start: 2021-12-15Target: 800Updated: 2025-04-07